H.C. Wainwright Starts Terns Pharmaceuticals (TERN) at Neutral
Tweet Send to a Friend
H.C. Wainwright analyst Andrew Fein initiates coverage on Terns Pharmaceuticals (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
